Loading...
Loading...
HFP-2026-133524-75F40126Q00256
Response Deadline
Jul 22, 2026, 2:00 PM(EDT)15 days
Eligibility
Contract Type
Combined Synopsis/Solicitation
COMBINED SYNOPSIS/SOLICITATION
Notice Type: Combined Synopsis/Solicitation
Solicitation Number: HFP-2026-133524
Title: Maxwell RSC 48 DNA Extraction Systems or Equal – Commercial Blanket Purchase Agreement (BPA)
Agency: Department of Health and Human Services (HHS), Food and Drug Administration (FDA), Office of Acquisitions and Grants Services (OAGS)
NAICS Code: 334516 – Analytical Laboratory Instrument Manufacturing
PSC: H266
Description
This is a combined synopsis/solicitation for commercial products prepared in accordance with the format prescribed in FAR 12.202, Streamlined Procedures for Evaluation and Solicitation for Commercial Products and Commercial Services, as supplemented with the additional information included in this notice. This announcement constitutes the only solicitation. Quotations are being requested, and a separate written solicitation will not be issued.
Solicitation Number HFP-2026-133524 is issued as a Request for Quotations (RFQ) for the acquisition of Maxwell RSC 48 DNA Extraction Systems or Equal, including delivery, installation, on-site training, warranty support, and related services for FDA laboratory facilities.
This acquisition is not set aside for small business concerns. It is being conducted using full and open competition. The solicitation incorporates provisions and clauses by reference. The full text of incorporated provisions and clauses is available at https://www.acquisition.gov.
Requirement
The contractor shall furnish all labor, materials, equipment, transportation, supervision, installation, training, warranty support, and incidental services necessary to provide Maxwell RSC 48 DNA Extraction Systems or Equal in accordance with the salient characteristics and performance requirements contained in the attached solicitation.
Equal products shall meet or exceed all required physical, functional, operational, and performance characteristics identified in the solicitation. Offerors proposing an equal product shall submit sufficient technical documentation to demonstrate compliance.
Delivery and Acceptance
Delivery shall be completed within 90 calendar days after receipt of order.
Installation shall be completed within 14 calendar days after delivery.
FOB: Destination.
Inspection and acceptance shall occur at destination after successful delivery, installation, operational testing, and completion of required training.
Initial delivery locations include FDA laboratory facilities located in Arkansas, Georgia, California, Colorado, Washington, and New York.
Solicitation Provisions
The following solicitation provisions apply to this acquisition:
Contract Clauses
The resulting BPA will incorporate the clauses identified in the attached solicitation, including:
Evaluation
Award will be made using the Lowest Price Technically Acceptable (LPTA) source selection process.
Evaluation factors are:
Submission Instructions
Questions are due July 10, 2026, at 10:00 a.m. Eastern Time.
Quotations are due July 22, 2026, at 10:00 a.m. Eastern Time.
Electronic quotations shall be submitted to the Contracting Officer at the email address identified in the solicitation.
Attachments
Point of Contact
Michele Jackson
Contracting Officer
Office of Acquisitions and Grants Services
U.S. Food and Drug Administration
See the attached solicitation for complete submission instructions and all applicable terms and conditions.
Michele Jackson
DEPARTMENT OF HEALTH AND HUMAN SERVICES
FOOD AND DRUG ADMINISTRATION
FOOD AND DRUG ADMINISTRATION
FOOD AND DRUG ADMINISTRATION
5630 FISHERS LANE
HFA-500
ROCKVILLE, MD, 20857
NAICS
Analytical Laboratory Instrument Manufacturing
PSC
EQUIPMENT AND MATERIALS TESTING- INSTRUMENTS AND LABORATORY EQUIPMENT
Set-Aside
No Set aside used